CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy

Acta Pharmacologica Sinica, Published online: 28 May 2020; doi:10.1038/s41401-020-0422-6CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy

Source: Acta Pharmacologica Sinica - May 27, 2020 Category: Drugs & Pharmacology Authors: Fu Li Jingrong Li Ke Yin Juan Zhang Zhen-hu Li Liang Lu Yuan-wu Bao Zhen Qin Yong Zheng Bao-tian Yang Jing Li Xinzhong Wang Source Type: research